AMBER DEMERATH: Open Payments
NPI 1356072417 · NEENAH, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,171 in 42 payments from 17 companies in 2025. Trend: 2023 $1,175 · 2024 $1,733 · 2025 $1,171
Food & beverage: $1,130Education: $41
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $240 |
| Amgen Inc. | 8 | $222 |
| GlaxoSmithKline, LLC. | 3 | $142 |
| SANOFI-AVENTIS U.S. LLC | 1 | $125 |
| Travere Therapeutics, Inc. | 2 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Ardelyx, Inc. | 3 | $53 |
| OPKO Pharmaceuticals, LLC | 2 | $41 |
| Lilly USA, LLC | 2 | $41 |
| Calliditas Therapeutics US Inc. | 2 | $40 |
Products named: Fabhalta, TAVNEOS, BENLYSTA, THYMOGLOBULIN, KRYSTEXXA, JARDIANCE, JYNARQUE, IBSRELA.
Industry payments across WI — which companies pay providers there.
